Addex Therapeutics Stock In The News

ADXN Stock  USD 7.53  0.58  7.15%   
Our overall analysis of Addex Therapeutics' news coverage and content from conventional and social sources shows investors' bearish mood towards Addex Therapeutics. The specific impact of Addex Therapeutics news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Addex Therapeutics' overall financial health and prospects. It also depends on the type and quality of a news publisher.
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Addex Therapeutics headlines in addition to utilizing other, more conventional financial analysis modules. Check out Addex Therapeutics Backtesting and Addex Therapeutics Hype Analysis.
To learn how to invest in Addex Stock, please use our How to Invest in Addex Therapeutics guide.

Addex Therapeutics Today Top News and Investor Outlook

Yahoo News
Addex Therapeutics Ltd (ADXN) Q2 2024 Earnings Call Transcript Highlights: Key Financials and ...
https://finance.yahoo.com/news/addex-therapeutics-ltd-adxn-q2-070037120.html
 Bullish
Yahoo News
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.02%
https://finance.yahoo.com/news/u-stocks-higher-close-trade-213506207.html
 Neutral
Yahoo News
Johnson Johnson-Partner Addex Therapeutics Selects Investigational Compound For Substance Use Disorder
https://finance.yahoo.com/news/johnson-johnson-partner-addex-therapeutics-124804531.html
 Neutral
Yahoo News
Johnson & Johnson-Partnered Addex Therapeutics' Epilepsy Candidate Fails Mid-Stage Study, Stock Tanks
https://finance.yahoo.com/news/johnson-johnson-partnered-addex-therapeutics-165351727.html
 Neutral
Yahoo News
15 Top Performing European Stocks So Far in 2024
https://finance.yahoo.com/news/15-top-performing-european-stocks-085734002.html
 Bullish
Yahoo News
15 Top Performing European Stocks So Far in 2023
https://finance.yahoo.com/news/15-top-performing-european-stocks-154624433.html
 Bullish
Yahoo News
Why Did HC Wainwright Downgrade Addex Therapeutics
https://finance.yahoo.com/news/why-did-hc-wainwright-downgrade-190330440.html
 Bullish
Yahoo News
The Daily Biotech Pulse: AbbVie's Migraine Drug OK'd By FDA, Amicus Spins Off Gene Therapy Business, Geovax In-Licenses Cancer Drug
https://finance.yahoo.com/news/daily-biotech-pulse-abbvies-migraine-121340191.html
 Neutral
Yahoo News
45 Stocks Moving In Tuesday's Mid-Day Session
https://finance.yahoo.com/news/45-stocks-moving-tuesdays-mid-160305467.html
 Bullish
Yahoo News
23 Stocks Moving in Tuesday's Pre-Market Session
https://finance.yahoo.com/news/23-stocks-moving-tuesdays-pre-111236575.html
 Neutral

Addex Therapeutics Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Addex and other traded companies coverage with news coverage. We help investors stay connected with Addex headlines for the 24th of November to make an informed investment decision based on correlating the impacts of news items on Addex Stock performance. Please note that trading solely based on the Addex Therapeutics hype is not for everyone as timely availability and quick action are needed to avoid losses.
Addex Therapeutics' linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Addex Therapeutics investors visualize upcoming and past events in order to time the market based on Addex Therapeutics noise-free hype analysis.
Addex Therapeutics stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Addex earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Addex Therapeutics that are available to investors today. That information is available publicly through Addex media outlets and privately through word of mouth or via Addex internal channels. However, regardless of the origin, that massive amount of Addex data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Addex Therapeutics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Addex Therapeutics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Addex Therapeutics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Addex Therapeutics alpha.

Addex Largest EPS Surprises

Earnings surprises can significantly impact Addex Therapeutics' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2021-11-04
2021-09-30-0.8527-0.7230.129715 
2021-05-05
2021-03-31-0.6565-0.52560.130919 
2021-08-05
2021-06-30-0.7876-0.9263-0.138717 
2022-03-10
2021-12-31-0.6492-0.8151-0.165925 
2023-05-11
2023-03-31-0.0516-0.2684-0.2168420 
2022-05-05
2022-03-31-0.5163-0.9136-0.397376 
View All Earnings Estimates

Addex Therapeutics Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Addex Therapeutics Stock. Current markets are strongly bullish. About 86% of major world exchanges and indexes are currently up. See today's market update for more information.
Google News at Macroaxis
22nd of November 2024
Addex Therapeutics Reports Substantial Asset Growth - TipRanks
at news.google.com 
Gurufocus Stories at Macroaxis
1st of October 2024
Addex Therapeutics Ltd Q2 2024 Earnings Call Transcript Highlights Key Financials and ...
at gurufocus.com 
seekingalpha News
19th of September 2024
Addex Therapeutics reports H1 results
at seekingalpha.com 
Google News at Macroaxis
3rd of September 2024
Addex to Participate in the H.C. Wainwright 26th Annual Global Investment Conference - Yah...
at news.google.com 

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Addex Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Addex Therapeutics' short interest history, or implied volatility extrapolated from Addex Therapeutics options trading.
When determining whether Addex Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Addex Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Addex Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Addex Therapeutics Stock:
Check out Addex Therapeutics Backtesting and Addex Therapeutics Hype Analysis.
To learn how to invest in Addex Stock, please use our How to Invest in Addex Therapeutics guide.
You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Addex Therapeutics. If investors know Addex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Addex Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(18.94)
Revenue Per Share
1.2
Quarterly Revenue Growth
(0.82)
Return On Assets
(0.62)
Return On Equity
(1.26)
The market value of Addex Therapeutics is measured differently than its book value, which is the value of Addex that is recorded on the company's balance sheet. Investors also form their own opinion of Addex Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Addex Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Addex Therapeutics' market value can be influenced by many factors that don't directly affect Addex Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Addex Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Addex Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Addex Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.